Et sinon, je n’ai toujours pas vu passer un avis scientifique clair pour savoir si les enfants peuvent contaminer les adultes ou non.
Et sinon, je n’ai toujours pas vu passer un avis scientifique clair pour savoir si les enfants peuvent contaminer les adultes ou non.
Background: On 07/02/2020, French Health authorities were informed of a confirmed case of SARS-CoV-2 coronavirus in an Englishman infected in Singapore who had recently stayed in a chalet in the French Alps. We conducted an investigation to identify secondary cases and interrupt transmission. Methods: We defined as a confirmed case a person linked to the chalet with a positive RT-PCR sample for SARS-CoV-2. Results: The index case stayed 4 days in the chalet with 10 English tourists and a family of 5 French residents; SARS-CoV-2 was detected in 5 individuals in France, 6 in England (including the index case), and 1 in Spain (overall attack rate in the chalet: 75%). One pediatric case, with picornavirus and influenza A coinfection, visited 3 different schools while symptomatic. One case was asymptomatic, with similar viral load as that of a symptomatic case. Seven days after the first cases were diagnosed, one tertiary case was detected in a symptomatic patient with a positive endotracheal aspirate; all previous and concurrent nasopharyngeal specimens were negative. Additionally, 172 contacts were monitored, including 73 tested negative for SARS-CoV-2. Conclusions: The occurrence in this cluster of one asymptomatic case with similar viral load as a symptomatic patient, suggests transmission potential of asymptomatic individuals. The fact that an infected child did not transmit the disease despite close interactions within schools suggests potential different transmission dynamics in children. Finally, the dissociation between upper and lower respiratory tract results underscores the need for close monitoring of the clinical evolution of suspect Covid-19 cases.
▻https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa424/5819060
Infants and young children are typically at high risk for admission to hospital after respiratory tract infection with viruses such as respiratory syncytial virus and influenza virus.8 Immaturity of the respiratory tract and immune system is thought to contribute to severe viral respiratory disease in this age group.8Therefore, the absence of paediatric patients with COVID19 has perplexed clinicians, epidemiologists, and scientists. Case definitions and management strategies for children are absent because of the limited number of paediatric patients with COVID19. In The Lancet Infectious Diseases, Haiyan Qiu and colleagues9have shed light on this underrepresented population with a clinical report of 36 paediatric patients (aged 1–16 years) with PCRconfirmed COVID19. Their analyses have important implications for clinical management of younger people with SARSCoV2 infection and social distancing policies to prevent virus transmission.
The patients in this study9 were being treated at three hospitals located in Zhejiang province, China, which is 900 km from Wuhan. The children accounted for roughly 5% of total patients with COVID19. Patients were stratified by disease severity and were assessed in hospital (mean duration of hospitalisation, 14 [SD 3] days) for secondary bacterial and fungal infection, sepsis, immune responses, and organ dysfunction (lung, liver, heart, and kidney). All children underwent CT examination for diagnosis of pneumonia.
Ten (28%) patients were asymptomatic latent cases identified because either an adult family member had the infection or they had been exposed to the epidemic area.9 Contact tracing was also used to identify paediatric infections during the SARSCoV and MERSCoV epidemics.4,5 None of the children developed severe illness or died, similar to findings of SARSCoV paediatric cases in 2002–03.4 The most commonly reported clinical finding in children with COVID19 was pneumonia (19 [53%]); fever, dry cough, or both were the next most frequent symptoms. All children with COVID19 were aggressively treated, which was also standard for children with SARSCoV infection.4 Treatment for COVID19 consisted of aerosolised interferon alfa in all children, lopinavir–ritonavir syrup twice a day for 14 days in 14 (39%), and supplemental oxygen for six (17%). Paediatric patients were discharged after two negative SARSCoV2 PCRs.
Qiu and colleagues have done a very important preliminary study defining the clinical picture for children infected with SARSCoV2, which will be valued globally. Although this work will assist with case identification, management, and social policy guidance, much more information is needed to establish the optimum management regimen. Specifically, the data showed that paediatric patients with COVID19 had mild or asymptomatic disease accompanied by pneumonia in about half the cases.9 It is unclear which children should be targeted for antiviral and immunomodulatory treatment, particularly in view of the high proportion of asymptomatic infected contacts. Together, these results could suggest that children have specific mechanisms regulating the interaction between the immune system and respiratory machinery, which could be contributing to milder disease. Possibly, lung infiltrates have a protective role during paediatric SARSCoV2 infection, similar to lymphocytes participating in inducible bronchusassociated lymphoid structure development after respiratory insult.10 Correlation between chest radiography and CT findings might give additional insight into the clinical importance, if any, of the CT findings. In view of the substantial radiation exposure associated with CT, if children are only experiencing mild disease, routine use of CT might not be warranted and needs further assessment for the management of paediatric cases.
The most important finding to come from the present analysis is the clear evidence that children are susceptible to SARSCoV2 infection, but frequently do not have notable disease, raising the possibility that children could be facilitators of viral transmission . If children are important in viral transmission and amplification, social and public health policies (eg, avoiding interaction with elderly people) could be established to slow transmission and protect vulnerable populations. There is an urgent need to for further investigation of the role children have in the chain of transmission .
▻https://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(20)30236-X.pdf
Oui, et médiatiquement et politiquement, c’est même : on ne sait pas et on s’en fout.
Pourtant ça m’a l’air un peu plus important pour tout de le monde que de mener une deux-centième étude pour savoir si la chloroquine soigne les hémorroïdes.